Aprocitentan
idorsia pharmaceuticals,janssen
['idorsia']
this is a reminder of our late-breaker session tomorrow at #aha22. we are excited to tell you about the results from our #resistanthypertension study! 3:10pm - 3:20pm (cst) 
The purpose of Idorsia is to discover, develop and bring more, innovative medicines to patients. See our community guidelines: https://t.co/qsjMiPDfhC